Calidi Biotherapeutics, Inc. — Form D
Calidi Biotherapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-06. The offering totals $5.5M, of which $5.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-06-06
- Form: D
- Accession: 0001855485-24-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.5M
- Investors: 9
- Date of first sale: 2024-06-03
- Revenue range: Decline to Disclose
- SEC file number: 021-515263
Issuer
- Name: Calidi Biotherapeutics, Inc.
- CIK: 0001855485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 4475 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-794-9600
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Allan Camaisa | Director | San Diego, CA |
| Scott R Leftwich | Director | San Diego, CA |
| George R Ng | Director | San Diego, CA |
| James A Schoeneck | Director | San Diego, CA |
| Alan R Stewart | Director | San Diego, CA |
| Allan Camaisa | Executive Officer | San Diego, CA |
| Andrew Jackson | Executive Officer | San Diego, CA |
| Boris Minev | Executive Officer | San Diego, CA |
| Wendy Pizarro | Executive Officer | San Diego, CA |
| David A LaPre | Director | San Diego, CA |
Other filings by this issuer (5)
More